Showing posts with label NVTR. Show all posts
Showing posts with label NVTR. Show all posts

Tuesday, August 29, 2017

Nevectra-Sold

This morning I deleted Nevectra (NVTR) from the Van Meerten New High portfolio at 10.55  It is not adding any value to the portfolio:


Barchart technical indicators:

  • 64% technical sell signals
  • Trend Spotter sell signal
  • Below its 20, 50 and 100 day moving averages
  • Relative Strength Index 35.70%
  • 29.40% off its recent high



Monday, June 19, 2017

5 Top Stocks to Own

Today I sorted Barchart's Top Stocks to Own list first by the highest Weighted Alpha, then by technical buy signals of 80% or more and lastly used the FlipChart feature to review the charts for consistency.  Today's Watch List includes:

Teladoc (TDOC), Sage Therapeutics (SAGE), Nevectra (NVTR), Impinj (PI) and Enzo Biochem (ENZ)

Teladoc (TDOC)


Barchart technical indicators:

  • 100% Barchart technical buy signals
  • Trend Spotter buy signal
  • Above its 20, 50 and 100 day moving averages
  • 9 new highs and up 19.06% in the last month
  • Relative Strength Index 68.255
  • Technical support level at 33.27
  • Recently traded at 35.35 with a 50 day moving average of 28.43


Barchart technical indicators:
  • 100% technical buy signals
  • Trend Spotter buy signal
  • Above its 20, 50 and 100 day moving averages
  • 12 new highs and up 27.33% in the last month
  • Relative Strength Index 74.83%
  • Technical support level at 77.08
  • Recently traded at 83.37 with a 50 day moving average of 70.82
Nevectra (NVTR)


Barchart technical indicators:
  • 100% technical buy signals
  • Trend Spotter buy signal
  • Above its 20, 50 and 100 day moving averages
  • 12 new highs and up 40.00% in the last month
  • Relative Strength Index 81.64%
  • Technical support level at 50.75
  • Recently traded at 56.91 with a 50 day moving average of 40.81
Impinj (PI)



Barchart technical indicators:
  • 100% technical buy signals
  • Trend Spotter buy signal
  • Above its 20, 50 and 100 day moving averages
  • 7 new highs and up 38.34% in the last month
  • Relative Strength Index 73.81%
  • Technical support level at 50.75
  • Recently traded at 56.91 with a 50 day moving average of 40.81



Barchart technical indicators:
  • 100% technical buy signals
  • Trend Spotter buy signal
  • Above its 20, 50 and 100 day moving averages
  • 9 new highs and up 19.73% in the last month
  • Relative Strength Index 70.55%
  • Technical support level at 10.41
  • Recently traded at 10.90 with a 50 day moving average of 9.07

Wednesday, June 14, 2017

Nuvectra - Chart of the Day

Nuvectra (NVTR) is the Barchart Chart of the Day.  The medical instrument company has a Trend Spotter buy signal, a Weighted Alpha of 91.32+ and gained 42.26% in the last year.

The Chart of the Day belongs to Nuvectra (NVTR).  I found the medical instrument stock by using Barchart to sort today's Top Stocks to Own list first for the highest Weighted Alpha, then again for technical buy signals of 80% or more.  Since the Trend Spotter signaled a buy in 4/21 the stock gained 53.32%

Nuvectra Corporation develops and commercializes neuromodulation medical device for the treatment of nervous system disorders. It also provides neural interface technology, components and systems, as well as NeuroNexus SmartBox portable control and data streaming systems. Nuvectra Corporation is based in Plano, Texas.


The status of Barchart's Opinion trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com web site when you read this report.

Barchart technical indicators:

  • 96% Technical buy signals
  • Trend Spotter buy signal
  • Above its 20, 50 and 100 day moving averages
  • 12 new highs and up 33.87% in the last month
  • Relative Strength Index 72.90%
  • Technical support level at 11.10
  • Recently traded at 11.59 with a 50 day moving average of 8.66
Fundamental factors:
  • Market Cap $ 119 million
  • Revenue expected to grow 120.10% this year and another 91.60% next year
  • Earnings estimated to increase 30.50% next year
  • The Wall Street analyst following the stock rates it a strong buy